Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Electronic applications for the CFQ-R scoring

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.

OriginalsprogEngelsk
TidsskriftRespiratory Research
Vol/bind18
Udgave nummer1
Sider (fra-til)e108
ISSN1465-9921
DOI
StatusUdgivet - 30 maj 2017

ID: 52170080